Lasmotinib, CAS [[2127107-15-5]]

Produktübersicht

• Artikelname: Lasmotinib, CAS [[2127107-15-5]]
• Artikelnummer: MCE-HY-153857
• Hersteller Artikelnummer: HY-153857
• Alternativnummer: MCE-HY-153857-10MG,MCE-HY-153857-25MG,MCE-HY-153857-1MG,MCE-HY-153857-100MG,MCE-HY-153857-5MG,MCE-HY-153857-50MG,MCE-HY-153857-10MMX1ML
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: PHI-101

Produktbeschreibung

Lasmotinib (PHI-101) is a FLT3 and CHK2 inhibitor. Lasmotinib potently inhibits FLT3 single activating mutations (ITD or TKD mutants) and has inhibitory activity against FLT3 double (ITD/D835Y or ITD/F691L) and triple (ITD/D835Y/F691L) resistance mutations. Lasmotinib synergizes with Venetoclax (HY-15531) or Azacytidine to inhibit leukemia. Lasmotinib exhibits anticancer activity against ovarian and breast cancer[1][2][3][4].

Produkteigenschaften

• Molekulargewicht: 386.44
• Reinheit: 98.97
• CAS Nummer: [2127107-15-5]
• Formel: C19H19FN4O2S
• Target-Kategorie: Checkpoint Kinase (Chk),FLT3

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound